Structure of Montelukast Sodium
CAS No.: 151767-02-1
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Montelukast Sodium is a potent, selective and competitive LTR1 antagonist with IC50 value < 5 nM, possesssing anti-inflammatory and bronchodilating activities.
Synonyms: MK0476; Montelukast(sodium salt); MK-476
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 151767-02-1 |
Formula : | C35H35ClNNaO3S |
M.W : | 608.17 |
SMILES Code : | CC(O)(C)C1=CC=CC=C1CC[C@H](C2=CC=CC(/C=C/C3=NC4=C(C=CC(Cl)=C4)C=C3)=C2)SCC5(CC5)CC([O-])=O.[Na+] |
Synonyms : |
MK0476; Montelukast(sodium salt); MK-476
|
MDL No. : | MFCD00931431 |
InChI Key : | LBFBRXGCXUHRJY-HKHDRNBDSA-M |
Pubchem ID : | 23663996 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H320-H335 |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
Lung ILC2 cells | 10^-6 M and 10^-8 M | 6 hours | To evaluate the effect of montelukast on LTD4-induced IL-4, IL-5, and IL-13 production by ILC2. Results showed that LTD4 significantly induced IL-4, IL-5, and IL-13 production by ILC2, and montelukast pretreatment blocked this effect. | PMC3704056 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
BALB/c mice | Mouse asthma model | 1 mg/kg | Subcutaneous osmotic pump | From Day 73 to Day 163, lasting 90 days | To evaluate the reversal effect of Montelukast on established airway remodeling. Results showed that Montelukast significantly reduced airway smooth muscle layer thickening and subepithelial collagen deposition/fibrosis. | PMC2662952 |
BALB/c mice | RSV infection model | 30 mg/kg | Oral | Once daily, from 1 day before primary infection to day 6 after infection | To evaluate the effects of montelukast on RSV-induced AHR and airway inflammation. Results showed that MK administered during primary infection reduced AHR and airway inflammation and increased IFN-γ production. | PMC2937239 |
Mice | Laser-induced choroidal neovascularization model | 1 mg/kg | Intraperitoneal injection | Daily from D0 to D6 | Montelukast inhibits CYP2C8, and combined with flunarizine further enhanced CNV suppression via tumor necrosis factor-α suppression. | PMC9535696 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT02110654 | Sinusitis Nas... More >>al Polyps Asthma Less << | Phase 4 | Unknown | June 2016 | China, Guangdong ... More >> the first affiliated hospital, Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510080 Contact: Fenghong Chen, doctor 02086013560170816 chfhong@mail.sysu.edu.cn Principal Investigator: jianbo Shi, doctor Less << |
NCT00504946 | Asthma | Phase 3 | Completed | - | Poland ... More >> Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland Lodz, Poland, 93-513 Less << |
NCT00398151 | Asthma | Phase 3 | Completed | - | - |
NCT00394160 | Bronchiolitis | Phase 2 | Completed | - | - |
NCT02720081 | Asthma | Phase 2 | Completed | - | - |
NCT00979901 | - | Completed | - | - | |
NCT01424124 | Asthma | Phase 2 | Completed | - | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less << |
NCT00756418 | Asthma | Phase 4 | Completed | - | - |
NCT02720081 | - | Completed | - | - | |
NCT02104674 | Asthma | Phase 3 | Completed | - | - |
NCT00551382 | Upper Respiratory Tract Infect... More >>ion Less << | Phase 3 | Unknown | June 2010 | Israel ... More >> Kupat Cholim Clalit Recruiting Lod, Israel Contact: Al Garushi Principal Investigator: Al Garushi, MD Kupat Cholim Clalit Recruiting Ramla, Israel Principal Investigator: Zachi Lotem Assaf Harofeh Recruiting Zerifin, Israel, 70300 Contact: Berkovitch 97289779152 Principal Investigator: Mati Berkovitch, MD Less << |
NCT02341573 | Childhood Asthma | Not Applicable | Completed | - | China, Shanghai ... More >> Department of Chinese Traditional Medicine; Children Hospital of Fudan University Shanghai, Shanghai, China, 201102 Less << |
NCT00492102 | Bronchopulmonary Dysplasia | Phase 1 | Completed | - | United States, Ohio ... More >> Good Samaritan Hospital Cincinnati, Ohio, United States, 45220-2489 Less << |
NCT03369119 | Acute Asthma ... More >>Acute Wheezy Bronchitis Less << | Phase 4 | Completed | - | Turkey ... More >> Kecioren Education and Training Hospital Ankara, Keçiören, Turkey, 06380 Less << |
NCT00273013 | Asthma | Phase 1 | Completed | - | United Kingdom ... More >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site London, United Kingdom, SE1 9RT Less << |
NCT00943683 | - | Completed | - | - | |
NCT00912171 | Obstructive Sleep Apnea Syndro... More >>me Less << | Phase 4 | Completed | - | Italy ... More >> Department if Pediatrics, Hospital S. Orsola-Malpighi , University of Bologna Bologna, Italy, 40138 Less << |
NCT00943683 | Asthma | Not Applicable | Completed | - | - |
NCT00913328 | Asthma | Phase 4 | Completed | - | - |
NCT00968149 | Seasonal Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00968149 | - | Completed | - | - | |
NCT00979901 | Seasonal Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00511316 | Eosinophilic Esophagitis | Phase 1 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
NCT00637611 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT00092144 | Asthma | Phase 3 | Completed | - | - |
NCT01140048 | - | Completed | - | - | |
NCT01140048 | - | Completed | - | - | |
NCT01770899 | Status Asthmaticus | Not Applicable | Unknown | - | United States, Illinois ... More >> Advocate Children's Hospital Oak Lawn Recruiting Oak Lawn, Illinois, United States, 60453 Principal Investigator: Corrie Fletcher, DO Less << |
NCT00273689 | Exercise Induced Bronchospasm | Phase 4 | Completed | - | United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less << |
NCT00442559 | Asthma Allerg... More >>ic Rhinitis Less << | Phase 4 | Completed | - | - |
NCT00442559 | - | Completed | - | - | |
NCT00524693 | Bronchiolitis | Not Applicable | Completed | - | - |
NCT00488176 | Seasonal Allergic Rhinitis | Phase 4 | Unknown | December 2013 | Poland ... More >> Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland Recruiting Lodz, Poland, 93-513 Contact: Violetta Ścibiorek, MD 00 48 42 689 59 72 alergol@kopernik.lodz.pl Principal Investigator: Iwona Stelmach, MD, PhD, Prof Less << |
NCT01943942 | Asthma | Phase 1 | Completed | - | - |
NCT01863654 | Asthma | Phase 1 | Completed | - | - |
NCT00289874 | Asthma | Phase 3 | Completed | - | - |
NCT00960141 | Seasonal Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00289874 | - | Completed | - | - | |
NCT00968201 | Asthma | Phase 3 | Completed | - | - |
NCT00351364 | Coronary Artery Disease|Acute ... More >>Coronary Syndrome Less << | PHASE4 | TERMINATED | 2025-07-10 | Foothills Medical Center, Calg... More >>ary, Alberta, T2N 2T9, Canada Less << |
NCT00960141 | - | Completed | - | - | |
NCT00968201 | - | Completed | - | - | |
NCT00337675 | Asthma | Phase 3 | Completed | - | - |
NCT00943397 | Asthma | Phase 3 | Completed | - | - |
NCT01852812 | Perennial Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00943397 | - | Completed | - | - | |
NCT00284856 | Asthma | Phase 3 | Completed | - | - |
NCT00337675 | - | Completed | - | - | |
NCT00284856 | - | Completed | - | - | |
NCT01621386 | Asthma | Phase 1 | Completed | - | United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less << |
NCT00092105 | Asthma, Bronchial ... More >> Rhinitis, Allergic, Perennial Less << | Phase 3 | Completed | - | - |
NCT00656058 | - | Completed | - | - | |
NCT00656058 | Bronchiolitis Obliterans ... More >> Chronic Graft Versus Host Disease Leukotriene Montelukast Stem Cell Transplant Less << | Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
NCT00770900 | Asthma | Phase 4 | Completed | - | - |
NCT00534976 | Exercise-induced Bronchoconstr... More >>iction (EIB) Less << | Phase 4 | Completed | - | - |
NCT01086527 | Asthma | Phase 1 | Unknown | September 2014 | United States, Florida ... More >> Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Mary K Warde, RN 904-697-3176 mwarde@nemours.org Principal Investigator: Edward B Mougey, Ph.D. Sub-Investigator: John J Lima, PharmD Sub-Investigator: Jason E Lang, MD Less << |
NCT00534976 | - | Completed | - | - | |
NCT01673620 | - | Completed | - | - | |
NCT01673620 | Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00863317 | - | Completed | - | - | |
NCT00394069 | Bronchiolitis | Phase 2 | Completed | - | - |
NCT01852812 | - | Completed | - | - | |
NCT00540839 | Asthma, Bronchial | Phase 3 | Withdrawn(Based on input from ... More >>regulatory agencies, it is not necessary to conduct this study. An ongoing study was sufficient for regulatory purposes.) Less << | - | - |
NCT00700661 | Asthma | Phase 3 | Completed | - | - |
NCT00380705 | Asthma Rhinit... More >>is Allergic Less << | Phase 4 | Completed | - | - |
NCT00117338 | - | Completed | - | - | |
NCT00445107 | Asthma | Phase 3 | Completed | - | - |
NCT00863317 | Bronchiolitis | Not Applicable | Completed | - | United States, Wisconsin ... More >> Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less << |
NCT00076973 | Bronchiolitis | Phase 3 | Completed | - | - |
NCT00664937 | Asthma, Exercise-induced | Phase 1 | Completed | - | - |
NCT02658422 | Respiratory Disorders ... More >> Asthma and Rhinitis Less << | Phase 1 | Completed | - | India ... More >> GSK Investigational Site Telangana, India, 500 013 Less << |
NCT00406094 | Rhinitis | Phase 4 | Unknown | December 2009 | United States, Ohio ... More >> Bernstein Allergy Group Recruiting Cincinnati, Ohio, United States, 45231 Contact: Jonathan A Bernstein, MD 513-931-0775 bernsteincrc@fuse.net Principal Investigator: Jonathan A Bernstein, MD Less << |
NCT00832455 | - | Completed | - | - | |
NCT00117338 | Asthma | Phase 3 | Completed | - | - |
NCT01659892 | Asthma | Early Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT01659905 | Asthma | Early Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT00545324 | Asthma | Phase 4 | Completed | - | - |
NCT01659918 | Asthma | Early Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT00446186 | Rhinitis Allergic | Phase 2 | Completed | - | - |
NCT00489346 | Asthma, Bronchial | Phase 3 | Completed | - | - |
NCT00638118 | Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT00832455 | Asthma | Phase 4 | Completed | - | - |
NCT00636207 | Asthma | Phase 1 | Completed | - | - |
NCT00739297 | Chronic Asthma | Phase 1 | Completed | - | - |
NCT01659931 | Asthma | Early Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT01491503 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less << |
NCT00442338 | - | Completed | - | - | |
NCT00636207 | - | Completed | - | - | |
NCT01857063 | Seasonal Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00442338 | Asthma | Phase 3 | Completed | - | - |
NCT01857063 | - | Completed | - | - | |
NCT00911547 | - | Completed | - | - | |
NCT00739297 | - | Completed | - | - | |
NCT00127647 | Rhinitis, Allergic, Seasonal | Phase 3 | Completed | - | - |
NCT00911547 | Asthma | Phase 3 | Completed | - | - |
NCT00641472 | Asthma | Phase 4 | Completed | - | - |
NCT01307462 | Bronchiolitis Obliterans | Phase 2 | Completed | - | United States, Arizona ... More >> Mayo Clinic - Scottsdale Scottsdale, Arizona, United States, 85054 United States, California Stanford University Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Maryland National Cancer Institute Experimental Transplantation & Immunology Branch Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less << |
NCT00092989 | Asthma | Phase 3 | Completed | - | - |
NCT00229970 | Asthma | Phase 3 | Completed | - | - |
NCT00157937 | Asthma Allerg... More >>ic Rhinitis Less << | Phase 4 | Completed | - | - |
NCT00140881 | Asthma | Phase 4 | Completed | - | - |
NCT00162864 | Asthma COPD | Phase 3 | Completed | - | United States, Oregon ... More >> Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 Less << |
NCT01307462 | - | Completed | - | - | |
NCT00140946 | Asthma | Phase 4 | Completed | - | - |
NCT02479854 | Healthy | Phase 1 | Completed | - | Egypt ... More >> Genuine Research Center GRC Cairo, Egypt Less << |
NCT01651481 | Rhinitis | Phase 1 | Completed | - | Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less << |
NCT01931501 | Healthy | Phase 1 | Completed | - | India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar, Gujarat, India, 382428 Less << |
NCT01931514 | Healthy | Phase 1 | Completed | - | India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar, Gujarat, India, 382428 Less << |
NCT01928069 | Healthy | Phase 1 | Completed | - | India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar,, Gujarat,, India, 382428 Less << |
NCT02480049 | Healthy | Phase 1 | Completed | - | Egypt ... More >> Genuine Research Center GRC Cairo, Egypt Less << |
NCT01928056 | Healthy | Phase 1 | Completed | - | India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar, Gujarat, India, 382428 Less << |
NCT01717625 | Premature Birth ... More >> Infant, Very Low Birth Weight Bronchopulmonary Dysplasia Less << | Phase 2 | Completed | - | Korea, Republic of ... More >> Ajou university medical center Suwon, Woncheon-dong, Yeongtong-gu,, Korea, Republic of, 443-721 Less << |
NCT00229970 | - | Completed | - | - | |
NCT01640535 | Perennial Allergic Rhinitis | Phase 3 | Completed | - | Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 Less << |
NCT00771160 | Rhinitis, Allergic | Phase 3 | Completed | - | - |
NCT00545844 | - | Completed | - | - | |
NCT02029313 | Asthma and Allergic Rhinitis | Phase 1 | Completed | - | Korea, Republic of ... More >> Inha University Hospital Incheon, Junggu, Korea, Republic of Less << |
NCT00755794 | Asthma | Phase 3 | Completed | - | - |
NCT00545844 | Asthma | Phase 4 | Completed | - | - |
NCT02322671 | Respiratory Disorders | Phase 1 | Completed | - | India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less << |
NCT01691456 | Healthy | Phase 1 | Completed | - | India ... More >> AXIS Clinicals Limited, Hyderabad, Andhra Pradesh, India, 500 049 Less << |
NCT01674504 | Healthy | Phase 1 | Completed | - | India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less << |
NCT01671709 | Healthy | Phase 1 | Completed | - | India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less << |
NCT01691469 | Healthy | Phase 1 | Completed | - | India ... More >> AXIS Clinicals Limited, Hyderabad, Andhra Pradesh, India, 500 049 Less << |
NCT02494466 | Airway Reactivity | Phase 4 | Completed | - | Turkey ... More >> Gulsah Karaoren Istanbul, Turkey Less << |
NCT01671722 | Healthy | Phase 1 | Completed | - | India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less << |
NCT01674517 | Healthy | Phase 1 | Completed | - | India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less << |
NCT04474327 | Neonatal Sepsis | PHASE1 | COMPLETED | 2021-02-10 | Mansoura University Childran H... More >>ospital, Mansoura, Dakahlia, 35116, Egypt Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.64mL 0.33mL 0.16mL |
8.22mL 1.64mL 0.82mL |
16.44mL 3.29mL 1.64mL |
|
Dissolving Methods |
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|